News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Orexo AB Plans Buyback Program of Company Shares


6/14/2012 11:17:15 AM

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: On June 4, 2012 Orexo announced that an agreement was reached with ProStrakan Group plc regarding AbstralĀ®, whereby Orexo acquired all rights for Abstral in the USA and restructured the existing royalty arrangements in both the EU and the rest of the world. In addition to future royalty and milestone payments, Orexo will receive a fixed net consideration of MGBP 55 (approximately MSEK 610), that will be paid during the coming 24 months.

Read at BioSpace.com

comments powered by Disqus
Orexo AB
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES